These experiments identify an Epstein-Barr virus-encoded gene product, called ZEBRA (BamHI fragment Z Epstein-Barr replication activator) protein, which activates a switch between the latent and replicative life cycle of the virus. Our previous work had shown that the 2.7-kilobase-pair WZhet (EBNAs), and a latent membrane protein (6, 11-13, 19, 25, 29 
The life cycle of the Epstein-Barr herpesvirus (EBV) in immortalized human B lymphocytes is divided into two phases called latency and replication. During latency the viral genome is circular and largely extrachromosomal. Only certain viral genes are expressed in latency: those encoding two small RNAs (EBERs), a family of at least four nuclear products (EBNAs) , and a latent membrane protein (6, 11-13, 19, 25, 29) . Latent EBV genomes replicate coordinately with the cell genome and are equally partitioned to daughter cells. The viral genome contains an origin of plasmid maintenance (oriP), which is thought to play a role in genome partitioning (34) . During the phase of viral replication a large number (more than 50) of new mature viral transcripts and as many viral polypeptides appear (14) . These are conventionally classified as early antigens (preceding viral DNA replication) and late antigens, including capsid and envelope antigens. Linear viral DNA is encapsidated into viral particles.
The switch between latency and replication can be activated by diverse stimuli including phorbol ester tumor promoters, sodium butyrate, anti-immunoglobulin, and a factor in serum (2, 18, 35) . The pathway by which these signals activate viral replication is unknown.
A class of defective EBV virions is also able to disrupt latency and activate replication of latent EBV (22) . These defective virions contain an extensively deleted and rearranged EBV genome, called heterogeneous (het) DNA. To identify the viral genes on het DNA which are responsible for disrupting latency, cloned het DNA fragments have been introduced into cells with a latent EBV genome. One DNA clone, termed BamtiHI WZhet or BamnHI het 2.7, is capable of activating the expression of many viral replicative polypeptides within 24 h after transfection into a monolayer somatic cell hybrid line, D98/HR-1, with a latent genome (5) . Up to 1% of transfected D98/HR-1 cells express replicative antigens, whereas less than 0.01%, of the cells spontaneously * Corresponding author. synthesize these products. The same DNA clone, when stably transferred into the X50-7 lymphoblastoid cell line, under drug selection also markedly enhanced expression of the viral replicative cycle (10) . Some clones of X50-7 cells which have received and express WZhet make viral replicative products in 10% of the cells, whereas less than 0.01% of parental X50-7 cells express replicative products. Furthermore X50-7 cells containing WZhet release infectious virus. Thus WZhet is competent to drive the EBV replicative cycle to completion with the synthesis of mature virions.
The active 2,700-base-pair (bp) WZhet fragment is extensively rearranged. It , and P3J-HR-1 were cloned into pSV2neo by using conventional techniques (28) . WZhet and standard BamHI-Z from the HR-1 strain were sequenced by the dideoxy chain-termination method (26) .
Mutant plasmids. Deletion mutants which invaded WZhet DNA from the 5' end were constructed by the Bal 31 exonuclease technique as described previously (24) . WZhet in pBR322 was linearized with EcoRI and digested for various lengths of time with Bal 31, and BamHI linkers were ligated onto the ends. The constructs were digested with BamHI and ligated into pSV2neo. The sizes of the deletions were determined by electrophoresis on polyacrylamide gels after digestion with SmaI and a variety of other restriction endonucleases.
Two site-specific mutants were generated at the HindIlI and NheI sites in BZLF1. The HindIll site was removed by filling in the 3' recessed ends left by HindlIl digestion by using the Klenow fragment of DNA polymerase I and deoxynucleotides, followed by religation. The NheI site was eliminated by removing the 5' overhang with mung bean nuclease followed by religation. WZhet fragments containing these mutations had lost the respective restriction endonuclease recognition site but were not otherwise altered in electrophoretic mobility.
A chimeric plasmid pSV2neo-WZhet-psi 1 was constructed to contain 5' sequences of WZhet (BamHI to HindIll) and 3' sequences from standard (HR-1) BamHI-Z (HindIll to BamHI). The 1.7-kbp BamHI-HindlIl subfragment of WZhet was subcloned from pSVod into pSV2neo. This plasmid is designated pCJ1.7. A HindIII fragment encompassing the carboxy end of standard HR-1 BZLF1 and adjacent sequences of pSV2neo was then cloned into pCJ1.7.
A second chimeric plasmid, pSV2neo-WZhet-psi 2, was constructed to contain 5' sequences of standard (HR-1) BamHI-Z (BamHI to the second HindIII site) and 3' sequences from WZhet (HindIII to BamHI). pSV2neo-Z (HR-1) was cleaved completely with EcoRI and only partially with HindIlI (partial digestion was monitored by agarose gel electrophoresis). When partial digestion was optimized, pSVOd-1.0 (5) , which had also been digested with EcoRI and HindIII was added, and the mixture was ligated. After identification of DNA clones containing the proper insert, the insert was recloned into the BamHI site of pSV2neo (see Fig. 8A ).
To COS-1 cells were used to examine chimeric plasmids for expression of proteins (8) . The cells were grown in Dulbecco modified minimal essential medium with 5% fetal bovine serum. They were maintained by weekly 20:1 cell splits and seeded at 5:1 cell splits into 100-mm petri dishes before transfection.
Transfection. D98/HR-1 cells and COS-1 cells were seeded into 100-mm petri dishes 3 days before transfection. D98/HR-1 cells were transfected with 8 ,ug of cloned DNA by the calcium method (9) . Transfers of 10 ,ug of DNA into COS-1 cells was by the DEAE-dextran method followed by treatment with chloroquine (21) .
Immunoblots. At 48 to 72 h after transfection, cells from a 100-mm dish were scraped into 0.5 ml of sodium dodecyl sulfate sample buffer. Extracts were sonicated for 15 s and boiled for 5 min. Approximately one third of each total extract was electrophoresed on a sodium dodecyl sulfate-10% polyacrylamide gel and transferred to a nitrocellulose filter (31) . A skim milk solution (Blotto) was used to block the filter before incubation with antibody (17) .
Antisera. Polyclonal human antiserum SC with high titers to EBV replicative proteins, including ZEBRA, came from a patient with putative chronic EBV infection. The serum was the gift of J. Jones, Denver, Colorado. A human antiserum, RM, from a healthy individual convalescent from mononucleosis was used to identify the latent EBV nuclear antigens (25) . A monospecific antiserum (Alexander) was prepared in a rabbit to a fusion protein between P-galactosidase and the last 330 nucleotides of BZLF1 (27) .
RESULTS
Structure of the WZhet fragment ( Fig. 1) . On the basis of nucleotide sequence, the rearranged EBV DNA fragment which activates the switch from the latent to the replicative life cycle of the virus is 2,711 bp in length. (H. Jenson and G. Miller, submitted for publication). It contains 1,134 bp from BamHI-W, the first large internal repeat in the genome, and 1,577 bp from BamHI-Z, a region which is more than 50 kbp away in the standard EBV genome. WZhet DNA contains only a single complete open reading frame (BZLF1 in the Cambridge terminology), whose orientation in the rearranged het DNA is opposite to that in the standard EBV genome (1) . Portions of three other open reading frames are represented in the active WZhet fragment; these are designated BWRF1 (in the BamHI-W region) and BRLF1 and BZLF2 (in the BamHI-Z portion). The junction between sequences derived from BamHI-W and those from BamHI-Z is at the first T in the sequence TATAAA which is thought to function as a TATA box for latent mRNAs (15) . Thus this TATA box is removed. Furthermore two exons of a multiply spliced latent nuclear protein encoded within BamHI-W are not found in WZhet (3).
One underlying purpose of our experiments was to learn whether this rearrangement of DNA affected the structure of a product responsible for activating EBV replication, for example, by fusing exons which were not contiguous on the genome. Accordingly we examined a series of deletion mutants which removed progressively more of the sequences from BamHI-W. The location of these deletions is shown in Fig. 1B Fig. 1 and Fig. 8 ) was constructed. WZhet-psi 1 produced a protein with electrophoretic mobility identical to that of the protein encoded by WZhet. The ZEBRA protein encoded by the second chimeric plasmid WZhet-psi 2 (see Fig. 8 (Fig. 2, lane 5 ; data not shown).
We examined deletion mutants which removed progressively more DNA from the BamHI-W region of the WZhet fragment for their capacity to express the product in COS-1 cells (Fig. 3) . A mutant such as number 81, which removed B -all but 147 bp of BamHI-W, still expressed a 43-kDa protein in COS-1 cells. Mutant number 80, which removed all of the BamHI W sequences as well as 73 bp from BRLF1, also expressed a 43-kDa protein, although in several trials less of the protein appeared to be made in COS-1 cells. These experiments showed that the differences in electrophoretic mobility between the 43-kDa WZhet protein and the 39-kDa standard Z (HR-1) protein were not due to fusion of exons which were derived from BamHI-W. A deletion mutant (number 28 in Fig. 3 ) which invaded BZLF1 did not make any proteins in COS-1 cells detectable by immunoblotting.
A plasmid which entirely eliminated the BZLF2 reading frame from mutant 81 by resection at the NcoI site also encoded the 43-kDa protein (data not shown; Countryman, Ph.D. thesis). Together these mutants narrowed the coding region for the 43-kDa ZEBRA protein to 1,335 bp within BamHI-Z, which contains only the BZLF1 open reading frame.
Antibodies raised in a rabbit to the carboxy end of BZLF1 expressed in bacteria as a lac fusion protein, detected the protein made in COS-1 cells (Fig. 4) . This antibody detected the same difference in electrophoretic mobility between WZhet and the standard Z (HR-1) protein which was seen with polyvalent antibodies.
These lines of evidence together indicate that the polymorphic protein seen after gene transfer into COS-1 cells is encoded entirely in sequences derived from a 1.3-kbp subfragment of BamHI-Z.
Disruption of latency by plasmids containing standard BamHI-Z sequences. One assay for disruption of latency is to measure on immunoblots the abundance of a number of EBV replicative polypeptides in D98/HR-1 cells which have been transfected with different plasmids (Fig. 5) . D98/HR-1 cells usually have a low background of cells spontaneously in- that brought about by other deletion mutants which retained more BamHI-W sequences.
The two site-directed mutations at the HindlIl and NheI sites in BZLF1, which destroyed the ability of the plasmids to express protein in COS-1 cells (Fig. 3) , also eliminated the capacity of these plasmids to induce replicative polypeptides ( Fig. 6 ; data not shown). Thus induction of the EBV replicative cycle required expression of the protein encoded by BZLF1. The minimal current limits of the DNA encoding the protein responsible for disruption of latency is about 1.3 kbp. Mutants BZLF1-5 and 80 define this limit (Fig. 7, 8, and 9 ).
DISCUSSION
Evidence that ZEBRA protein is required for disruption of latency. The purpose of our experiments was to ask whether disruption of EBV latency by the 2.7-kbp WZhet DNA fragment occurred by virtue of a protein product encoded by this DNA. Preliminary data showed that, when cleaved at the HindlIl site in BZLF1, plasmids containing WZhet were no longer able to disrupt latency (5) . But this cleavage could have interrupted a protein-binding domain on the DNA or a protein-coding domain; therefore the experiments were not conclusive.
We have now obtained several lines of evidence which indicate that the 43-kDa protein encoded by the BZLF1 reading frame in WZhet is responsible for the activation of expression of replicative polypeptides. Deletional and sitedirected mutants in BZLF1 which are unable to express the ZEBRA protein in CQS-1 cells (Fig. 2 and 3 ) are likewise unable to induce expression of replicative proteins in D98/HR-1 cells (Fig. 5, 6, and 7) . Standard viruses without defective genomes encode ZEBRA proteins which vary from that encoded by WZhet both in electrophoretic mobility (Fig. 2) and in their capacity to disrupt latency (Fig. 5 and 6) . Thus there appears to be a family of ZEBRA proteins which vary in their electrophoretic mobility and in their biologic activity. This might account for differences among EBVs in their tendency to enter the replicative life cycle spontaneously or in their capacity to disrupt latency when added to cells with a latent genome. In related experiments we have studied ZEBRA expression during constitutive expression of the viral replicative life cycle in cell lines which spontaneously make virus and after induction of replication by TPA or butyrate (N. Taylor, J. Countryman, C. Rooney, D. Katz, and G. Miller, manuscript in preparation). Using a potent antiserum to ZEBRA we have detected ZEBRA expression whenever the viral replicative cycle is activated. Thus ZEBRA expression does not require defective virus, but is an invariant marker for switch of the virus from latency to replication.
Differences in electrophoretic mobility of ZEBRA proteins. According to DNA sequence data which will be presented in detail elsewhere (Jenson and Miller, submitted) , the BZLF1 from B95-8 virus (the prototype transforming strain which was completely sequenced [1] ) differs considerably from that in HR-1 virus, the nonimmortalizing EBV strain which was the source of the defective virus. The reading frame is 27 bp longer in HR-1, and there is a frameshift which could result in the translation of a protein which differs in its carboxy end ( Fig. 8 and 9 ; data not shown). In addition there are 27 scattered bp changes of which 15 result in an amino acid change. This might explain the reproducible difference seen in the electrophoretic mobility between ZEBRAs from B95-8 and HR-1 ( Fig. 2 and 3) .
However there is also a reproducible 4-kDa difference in electrophoretic mobility between ZEBRA made from the HR-1 defective virus and that made by the HR-1 standard virus (Fig. 2, 3 , and 4). Although this difference is only illustrated in this report in COS-1 cells transfected with pSV2neo-Z (HR-1) and pSV2neo-WZhet ( Fig. 2 and 3 ity, which is an extremely useful marker (Fig. 2, 3, and 4 What is novel in our report is the correlation between structural and functional studies. By using a variety of mutants we were able to show that expression of the ZEBRA proteins is needed for disruption of latency in D98/HR-1 cells.
Role of the rearranged sequences in WZhet. Our experiments show that the sequences from BamHI-W do not play a role in encoding the WZhet protein (Fig. 3) (Fig. 1) . Defective genomes may lack negative regulatory signals usually present in standard virus or may contain novel positive-regulatory elements in the upstream region of the ZEBRA gene. The deciphering of these signals will be needed to learn why ZEBRA expression is usually suppressed during EBV latency.
